Reports for XOLAIR
Brand name
XOLAIR
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
|
Drug Identification Number
02260565 |
Ingredients
OMALIZUMAB |
Ingredient Strength
150 MG |
ATC Code
R03DXR03DX |
ATC Descriptor
OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| XOLAIR | 1 x 5mL | Resolved | 2023-11-22 | 2024-04-10 | 211221 |
| XOLAIR | 1 X 5ML | Anticipated shortage | 2024-04-10 | 2024-04-10 | 224781 |
Showing 1 to 2 of 2
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0